FDA Circular No. 2020-027

FDA Circular No. 2020-027 || Conduct of Risk-Based Local Inspections in Light of the COVID-19 Pandemic

OBJECTIVES:

This Circular aims to provide guidelines on the conduct of risk-based local inspections to carry out the FDA’s regulatory mission while protecting the health, safety, and well-being of the inspectors and the public.

Read more:->https://bit.ly/34uWNBt

Post from Food and Drug Administration Philippines.

Leave a comment